W. T. Garvey, “EFFICACY AND SAFETY OF LIRAGLUTIDE 3.0 mg IN INDIVIDUALS WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (T2D) TREATED WITH BASAL INSULIN: THE SCALE INSULIN TRIAL”, J ASEAN Fed Endocr Soc, vol. 34, no. 2, p. 12, May 2022.